Alkyl chlorides
Aobchem 1 2 5-Trichloro-3-methoxybenzene | 95% | CAS 54135-81-8 | C7H5Cl3O | 1g
1 2 5-Trichloro-3-methoxybenzene | 95% | CAS 54135-81-8 | C7H5Cl3O | 1g
Aobchem 2 2 2-Trichloro-1-(4-fluorophenyl)ethanol | 95% | CAS 394-56-9 | C8H6Cl3FO | 5g
2 2 2-Trichloro-1-(4-fluorophenyl)ethanol | 95% | CAS 394-56-9 | C8H6Cl3FO | 5g
Aobchem 1 3 5-Trichloro-2-(chloromethyl)benzene | ≥95% | CAS 17293-03-7 | C7H4Cl4 | 1g
1 3 5-Trichloro-2-(chloromethyl)benzene | ≥95% | CAS 17293-03-7 | C7H4Cl4 | 1g
Medchemexpress LLC UC-112 | 383392-66-3 | 98.9% | 10 MG
UC-112 is a survivin and XIAP modulator that exhibits anticancer activity. It selectively downregulates and degrades survivin through the ubiquitin-mediated proteasomal degradation pathway and also reduces XIAP levels in in vivo tumor models. UC-112 activates caspase-3/7 and caspase-9, leading to cancer cell apoptosis. It is suitable for studies related to melanoma, prostate cancer, and other cancer research.
- Selectively downregulates and degrades survivin via the ubiquitin-mediated proteasomal degradation pathway.
- Reduces XIAP levels in in vivo tumor models.
- Activates caspase-3/7 and caspase-9, inducing cancer cell apoptosis.
- Applicable to studies on melanoma, prostate cancer, and cancer-related research.
- Potently inhibits proliferation of A375, M14, PC-3, and DU145 cancer cells.
- Alters cell cycle distribution of A375 melanoma cells.
Aobchem 1 2 4-Trichloro-5-methylbenzene | ≥97% | CAS 6639-30-1 | C7H5Cl3 | 5g
1 2 4-Trichloro-5-methylbenzene | ≥97% | CAS 6639-30-1 | C7H5Cl3 | 5g
Aobchem 1 2 4-Trichloro-3-methoxybenzene | ≥95% | CAS 50375-10-5 | C7H5Cl3O | 1g
1 2 4-Trichloro-3-methoxybenzene | ≥95% | CAS 50375-10-5 | C7H5Cl3O | 1g
eMolecules 86399-04-4 | ChemScene | 236-Trichloro-4-(trifluoromethyl)aniline | 1g | 632274475 | CS-0182827 | MFCD04972973 | 264.45 | C7H3Cl3F3N
ChemScene | 236-Trichloro-4-(trifluoromethyl)aniline | 1g | 632274475 | CS-0182827 | 86399-04-4 | MFCD04972973 | 264.450 | C7H3Cl3F3N
Medchemexpress LLC Rapastinel Trifluoroacetate | 1435786-04-1 | 98.0% | 527.49 | 100 MG
Rapastinel Trifluoroacetate (GLYX-13 Trifluoroacetate) is an NMDA receptor modulator with glycine-site partial agonist properties. It has potential for treating major depressive disorder and is currently in phase II clinical development as an adjunctive therapy for this condition. Studies have shown that Rapastinel Trifluoroacetate produces an antidepressant-like effect and an anxiolytic effect in animal models, without altering locomotor activity.
- NMDA receptor modulator with glycine-site partial agonist properties
- Potential for treating major depressive disorder
- Phase II clinical development as an adjunctive therapy
- Produces antidepressant-like and anxiolytic effects in animal models
- Does not alter locomotor activity
Aobchem 1 2 4-Trichloro-5-fluorobenzene | ≥95% | CAS 400-04-4 | C6H2Cl3F | 500mg
1 2 4-Trichloro-5-fluorobenzene | ≥95% | CAS 400-04-4 | C6H2Cl3F | 500mg
Aobchem 1 2 4-Trichloro-5-fluorobenzene | ≥95% | CAS 400-04-4 | C6H2Cl3F | 5g
1 2 4-Trichloro-5-fluorobenzene | ≥95% | CAS 400-04-4 | C6H2Cl3F | 5g
Aobchem 2 3 5-Trichloro-6-methoxypyridine | ≥97% | CAS 31557-34-3 | C6H4Cl3NO | 5g
2 3 5-Trichloro-6-methoxypyridine | ≥97% | CAS 31557-34-3 | C6H4Cl3NO | 5g
Medchemexpress LLC 2 3 5-Trichloro-4-py 50mg
2 3 5-Trichloro-4-pyridinol can be used as a herbicide for direct-seeded and flooded rice[1]
Medchemexpress LLC TL13-112 | 2229037-19-6 | MFCD12922943 | 98.0% | 1002.57 | C49H60ClN9O10S | 10MM 1ML
TL13-112 is a proteolysis targeting chimera (PROTAC) designed to selectively induce degradation of anaplastic lymphoma kinase (ALK) in cellular models. It is supplied as a solid and as a 10 mM solution in DMSO for use in preclinical degradation studies, mechanistic assays, and target validation workflows.
- Selective ALK degradation in cellular assays.
- High purity suitable for biological studies.
- Available as solid or 10 mM DMSO solution for convenient dosing.
- Recommended storage conditions for powder and solvent preparations.
- Applicable to mechanistic studies and preclinical target validation.
Aobchem 4-(1-Pyrrolidinyl)-3-(trifluoromethyl)benzaldehyde | ≥97% | CAS 886500-73-8 | C12H12F3NO | 500mg
4-(1-Pyrrolidinyl)-3-(trifluoromethyl)benzaldehyde | ≥97% | CAS 886500-73-8 | C12H12F3NO | 500mg